ctrl K

Watchlist Price Alert

Aerovate Therapeutics Inc... (AVTE)

NASDAQ: AVTE · Real-Time Price · USD

2.68

0.00 (0.00%)

At close: Apr 28, 2025, 3:59 PM

2.68

0.00%

After-hours: Apr 28, 2025, 04:00 PM EDT

Aerovate Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	33.75M	23.49M	22.4M	54.2M	4.57M	3.51M
Short-Term Investments	44.87M	98.95M	106.82M	113.18M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	2.28M	2.56M	302K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	845K	250K	295K	240K	38K	n/a
Total Current Assets	80.12M	124.23M	131.5M	174.33M	4.68M	3.51M
Property-Plant & Equipment	215K	902K	1.25M	728K	39K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	215K	3.19M	3.81M	1.03M	39K	n/a
Total Assets	80.33M	127.42M	135.3M	175.36M	4.71M	3.51M
Account Payables	224K	2.4M	2.58M	1.21M	612K	542K
Deferred Revenue	n/a	n/a	n/a	1.01M	n/a	n/a
Short-Term Debt	n/a	n/a	385K	192K	n/a	n/a
Other Current Liabilities	319K	1.09M	2.75M	168K	970K	4K
Total Current Liabilities	3.83M	17.64M	7.78M	2.55M	1.77M	657K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	2.5M
Other Long-Term Liabilities	70K	70K	71K	13K	n/a	4M
Total Long-Term Liabilities	70K	325K	776K	395K	16.29M	6.5M
Total Liabilities	3.9M	17.96M	8.56M	2.94M	18.06M	7.16M
Total Debt	417K	675K	1.09M	574K	n/a	2.5M
Common Stock	3K	3K	2K	2K	n/a	n/a
Retained Earnings	-233.05M	-163.42M	-87.9M	-36.39M	-13.41M	-3.64M
Comprehensive Income	105K	237K	-466K	-59K	n/a	n/a
Shareholders Equity	76.43M	109.46M	126.74M	172.42M	-13.34M	-3.64M
Total Investments	44.87M	98.95M	106.82M	113.18M	n/a	n/a